|
G |
Abcb11 |
ATP-binding cassette, sub-family B member 11 |
decreases activity multiple interactions |
ISO |
telmisartan results in decreased activity of ABCB11 protein telmisartan inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] |
CTD |
PMID:20829430 PMID:23956101 PMID:24014644 |
|
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
multiple interactions increases expression |
ISO |
PPARG mutant form inhibits the reaction [telmisartan results in increased expression of ABCG1 mRNA] |
CTD |
PMID:22124178 |
|
NCBI chr17:31,276,668...31,336,958
Ensembl chr17:31,276,649...31,336,962
|
|
G |
Ace |
angiotensin I converting enzyme |
decreases expression multiple interactions |
ISO |
Telmisartan results in decreased expression of ACE mRNA; Telmisartan results in decreased expression of ACE protein Telmisartan inhibits the reaction [Pregabalin results in increased expression of ACE protein] |
CTD |
PMID:19171132 PMID:25973029 PMID:29909460 PMID:31629013 |
|
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
multiple interactions increases expression decreases expression decreases expression |
EXP ISO |
telmisartan inhibits the reaction [Streptozocin results in decreased expression of ACE2 protein] Telmisartan results in increased expression of ACE2 mRNA; Telmisartan results in increased expression of ACE2 protein Telmisartan results in decreased expression of ACE2 mRNA; Telmisartan results in decreased expression of ACE2 protein Telmisartan inhibits the reaction [Pregabalin results in decreased expression of ACE2 protein] telmisartan decreases expression of mRNA in mandible of rats with periodontal disease |
CTD RGD |
PMID:21381899 PMID:25973029 PMID:28656296 PMID:29909460 PMID:31629013 PMID:33364953 More...
|
RGD:329956421 |
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [telmisartan inhibits the reaction [Streptozocin results in increased activity of ACHE protein]]; telmisartan inhibits the reaction [Streptozocin results in increased activity of ACHE protein] |
CTD |
PMID:23060470 |
|
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
decreases activity |
ISO |
telmisartan decreases enzyme activity of Trap, Acp5 in serum of rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr 9:22,038,023...22,047,042
Ensembl chr 9:22,038,023...22,047,007
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
increases expression |
EXP ISO |
telmisartan results in increased expression of ADIPOQ mRNA telmisartan results in increased expression of ADIPOQ protein |
CTD |
PMID:19730415 PMID:20555330 |
|
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
|
|
G |
Agt |
angiotensinogen |
multiple interactions decreases expression |
EXP ISO |
telmisartan inhibits the reaction [[AGT protein modified form co-treated with AGTR1A co-treated with AGTR1B] results in increased expression of SERPINE1 mRNA]; telmisartan inhibits the reaction [AGT protein results in increased expression of IL6 protein] Telmisartan inhibits the reaction [AGT protein results in decreased expression of PLAU mRNA]; Telmisartan inhibits the reaction [AGT protein results in decreased expression of SYP protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of AGTR1A mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1G mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1H mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of CRH protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of FN1 mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of FN1 protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of FOS protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of IL1B protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of IL6 protein]; Telmisartan inhibits the reaction [AGT protein results in increased expression of SERPINE1 mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of TGFB1 protein]; Telmisartan inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]; Telmisartan inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]; Telmisartan inhibits the reaction [AGT protein results in increased ubiquitination of SYP protein]; Telmisartan inhibits the reaction [arsenite results in increased expression of AGT protein]; Telmisartan inhibits the reaction [Diatrizoate results in increased expression of AGT protein]; Telmisartan inhibits the reaction [Iohexol results in increased expression of AGT protein]; Telmisartan inhibits the reaction [Pregabalin results in decreased expression of AGT protein] telmisartan results in decreased expression of AGT mRNA; telmisartan results in decreased expression of AGT protein |
CTD |
PMID:9533614 PMID:17620961 PMID:18487452 PMID:19171132 PMID:19289654 PMID:19292980 PMID:19452295 PMID:19706694 PMID:31629013 PMID:33872574 PMID:34339004 More...
|
|
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
multiple interactions decreases expression affects binding increases expression decreases expression |
EXP ISO |
telmisartan inhibits the reaction [[AGT protein modified form co-treated with AGTR1A co-treated with AGTR1B] results in increased expression of SERPINE1 mRNA]; telmisartan inhibits the reaction [Streptozocin results in increased expression of AGTR1A protein] telmisartan results in decreased expression of AGTR1A mRNA telmisartan binds to and results in decreased activity of AGTR1 protein telmisartan binds to AGTR1 protein Telmisartan binds to and results in decreased activity of AGTR1 protein; Telmisartan inhibits the reaction [AGT protein results in increased expression of AGTR1A mRNA]; Telmisartan inhibits the reaction [Daunorubicin results in increased expression of AGTR1A protein]; Telmisartan inhibits the reaction [Pregabalin results in increased expression of AGTR1 protein] telmisartan results in increased expression of AGTR1 mRNA telmisartan decreases expression of mRNA in mandible of rats with periodontal disease |
CTD RGD |
PMID:8220885 PMID:9533614 PMID:9728324 PMID:17620961 PMID:19171132 PMID:19706694 PMID:20888384 PMID:21381899 PMID:21557540 PMID:31629013 PMID:33364953 More...
|
RGD:329956421 |
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
|
|
G |
Agtr1b |
angiotensin II receptor, type 1b |
multiple interactions |
EXP |
telmisartan inhibits the reaction [[AGT protein modified form co-treated with AGTR1A co-treated with AGTR1B] results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:17620961 |
|
NCBI chr 3:20,368,637...20,421,341
Ensembl chr 3:20,368,637...20,421,341
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
increases expression |
ISO |
telmisartan increases expression of mRNA in mandible of rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr X:21,350,863...21,355,072
Ensembl chr X:21,350,783...21,355,403
|
|
G |
Ahr |
aryl-hydrocarbon receptor |
increases activity |
ISO |
Telmisartan results in increased activity of AHR protein |
CTD |
PMID:28728110 |
|
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
|
|
G |
Alb |
albumin |
affects expression multiple interactions |
ISO EXP |
telmisartan affects the expression of ALB protein modified form Telmisartan affects the reaction [LEPR protein affects the abundance of ALB protein] |
CTD |
PMID:16671338 PMID:34464088 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
increases activity multiple interactions |
ISO |
telmisartan increases enzyme activity of Alpl in serum of rats with periodontal disease Telmisartan inhibits the reaction [Methotrexate results in increased expression of and results in increased secretion of ALPL protein] |
CTD RGD |
PMID:27269004 PMID:33364953 |
RGD:329956421 |
NCBI chr 4:137,469,042...137,523,695
Ensembl chr 4:137,469,044...137,523,695
|
|
G |
Ang2 |
angiogenin, ribonuclease A family, member 2 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of ANG2 protein] |
CTD |
PMID:23750309 |
|
NCBI chr14:51,432,781...51,436,400
Ensembl chr14:51,432,781...51,436,605
|
|
G |
Bax |
BCL2-associated X protein |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BAX mRNA] |
CTD |
PMID:24831514 |
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA] |
CTD |
PMID:24831514 |
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bdnf |
brain derived neurotrophic factor |
multiple interactions |
EXP |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BDNF mRNA]; telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BDNF protein] |
CTD |
PMID:23747572 |
|
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
|
|
G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
multiple interactions decreases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Telmisartan results in decreased expression of CACNA1G mRNA]; SB 203580 inhibits the reaction [Telmisartan results in decreased expression of CACNA1G mRNA]; Telmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1G mRNA] telmisartan results in decreased expression of CACNA1G mRNA |
CTD |
PMID:19292980 |
|
NCBI chr11:94,299,217...94,365,226
Ensembl chr11:94,299,217...94,365,024
|
|
G |
Cacna1h |
calcium channel, voltage-dependent, T type, alpha 1H subunit |
multiple interactions decreases expression |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [telmisartan results in decreased expression of CACNA1H mRNA]; SB 203580 inhibits the reaction [telmisartan results in decreased expression of CACNA1H mRNA]; telmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1H mRNA] |
CTD |
PMID:19292980 |
|
NCBI chr17:25,593,259...25,655,308
Ensembl chr17:25,593,259...25,652,759
|
|
G |
Casp3 |
caspase 3 |
multiple interactions decreases expression |
ISO EXP |
telmisartan inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP3 protein] telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 protein]; telmisartan inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein] Telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 protein]; Telmisartan inhibits the reaction [Diatrizoate results in increased activity of CASP3 protein]; Telmisartan inhibits the reaction [Iohexol results in increased activity of CASP3 protein]; Telmisartan inhibits the reaction [Methotrexate results in increased expression of CASP3 protein]; Telmisartan inhibits the reaction [sodium arsenite results in increased expression of CASP3]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of and results in increased activity of CASP3 protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CASP3 mRNA] Telmisartan results in decreased expression of CASP3 protein |
CTD |
PMID:18565324 PMID:19452295 PMID:21620867 PMID:21819444 PMID:22750630 PMID:24831514 PMID:26439596 PMID:27269004 PMID:29909460 More...
|
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [arsenite results in decreased activity of CAT protein]; Telmisartan inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Telmisartan inhibits the reaction [Carbon Tetrachloride results in decreased activity of CAT protein] |
CTD |
PMID:23750309 PMID:26929000 PMID:34339004 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases expression |
ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 protein] telmisartan results in decreased expression of CCL2 protein |
CTD |
PMID:17922026 PMID:22124178 |
|
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
decreases response to substance |
ISO |
telmisartan results in decreased susceptibility to CCL5 protein |
CTD |
PMID:18158351 |
|
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
decreases expression |
ISO |
telmisartan results in decreased expression of CCR2 mRNA |
CTD |
PMID:17922026 |
|
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
|
|
G |
Cd36 |
CD36 molecule |
increases expression multiple interactions |
ISO |
telmisartan results in increased expression of CD36 mRNA PPARG mutant form inhibits the reaction [telmisartan results in increased expression of CD36 mRNA]; T 0070907 inhibits the reaction [telmisartan results in increased expression of CD36 mRNA] |
CTD |
PMID:22124178 |
|
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
ISO |
telmisartan inhibits the reaction [TNF protein promotes the reaction [CEBPB protein binds to IL6 promoter]] |
CTD |
PMID:19289654 |
|
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
|
|
G |
Crh |
corticotropin releasing hormone |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [AGT protein results in increased expression of CRH protein] |
CTD |
PMID:33872574 |
|
NCBI chr 3:19,747,565...19,749,560
Ensembl chr 3:19,747,565...19,749,560
|
|
G |
Crp |
C-reactive protein, pentraxin-related |
decreases expression |
ISO |
telmisartan results in decreased expression of CRP protein |
CTD |
PMID:20555330 |
|
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
|
|
G |
Ctsk |
cathepsin K |
decreases expression |
ISO |
telmisartan decreases expression of mRNA in mandible of rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr 3:95,406,521...95,416,698
Ensembl chr 3:95,406,567...95,416,673
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
multiple interactions decreases response to substance |
ISO |
PPARG protein promotes the reaction [telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein]]; telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein] telmisartan results in decreased susceptibility to CXCL12 protein |
CTD |
PMID:18158351 |
|
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
decreases expression |
ISO |
telmisartan metabolite results in decreased expression of CXCL8 mRNA |
CTD |
PMID:26528891 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
decreases expression |
ISO |
telmisartan decreases expression of protein in mandible of SHR rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
|
|
G |
Cyba |
cytochrome b-245, alpha polypeptide |
decreases expression multiple interactions |
EXP ISO |
telmisartan results in decreased expression of CYBA mRNA; telmisartan results in decreased expression of CYBA protein telmisartan inhibits the reaction [Daunorubicin results in increased expression of CYBA protein] |
CTD |
PMID:16141465 PMID:19171132 PMID:21054405 |
|
NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
|
|
G |
Cybb |
cytochrome b-245, beta polypeptide |
multiple interactions decreases expression |
EXP ISO |
telmisartan inhibits the reaction [Streptozocin results in increased expression of CYBB protein] telmisartan results in decreased expression of CYBB mRNA Telmisartan inhibits the reaction [Glucose results in increased expression of CYBB mRNA]; Telmisartan inhibits the reaction [Glucose results in increased expression of CYBB protein] Telmisartan inhibits the reaction [arsenite results in increased expression of CYBB mRNA] |
CTD |
PMID:19171132 PMID:21381899 PMID:34339004 PMID:34464088 |
|
NCBI chr X:9,301,493...9,354,005
Ensembl chr X:9,301,491...9,354,010
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of CYCS mRNA] |
CTD |
PMID:24831514 |
|
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
|
|
G |
Cyp2j9 |
cytochrome P450, family 2, subfamily j, polypeptide 9 |
decreases activity |
ISO |
Telmisartan results in decreased activity of CYP2J2 protein |
CTD |
PMID:30965050 |
|
NCBI chr 4:96,456,661...96,480,748
Ensembl chr 4:96,456,666...96,479,815
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
decreases expression |
ISO |
telmisartan results in decreased expression of DDIT3 protein |
CTD |
PMID:19102871 |
|
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
|
|
G |
Edn1 |
endothelin 1 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Daunorubicin results in increased expression of EDN1 protein] |
CTD |
PMID:20888384 |
|
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
|
|
G |
Ednra |
endothelin receptor type A |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Daunorubicin results in increased expression of EDNRA protein] |
CTD |
PMID:20888384 |
|
NCBI chr 8:78,389,658...78,451,081
Ensembl chr 8:78,389,660...78,451,093
|
|
G |
Ednrb |
endothelin receptor type B |
multiple interactions |
ISO |
telmisartan promotes the reaction [Daunorubicin results in increased expression of EDNRB protein] |
CTD |
PMID:20888384 |
|
NCBI chr14:104,052,055...104,081,764
Ensembl chr14:104,052,061...104,081,838
|
|
G |
Fasl |
Fas ligand |
multiple interactions |
EXP ISO |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of FASL protein] telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of FASLG protein] |
CTD |
PMID:21620867 PMID:21819444 |
|
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [AGT protein results in increased expression of FN1 mRNA]; telmisartan inhibits the reaction [AGT protein results in increased expression of FN1 protein] |
CTD |
PMID:19706694 |
|
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [AGT protein results in increased expression of FOS protein] |
CTD |
PMID:33872574 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Gdnf |
glial cell line derived neurotrophic factor |
multiple interactions |
EXP |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GDNF mRNA]; telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GDNF protein] |
CTD |
PMID:23747572 |
|
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions decreases expression |
EXP ISO |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of GFAP protein] Telmisartan results in decreased expression of GFAP protein |
CTD |
PMID:23747572 PMID:29909460 |
|
NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of GGT1 protein] |
CTD |
PMID:23750309 |
|
NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [Dibutyl Phthalate results in increased expression of GJA1 protein] |
CTD |
PMID:37356649 |
|
NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [Methotrexate results in increased expression of and results in increased secretion of GOT1 protein] |
CTD |
PMID:27269004 |
|
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [Carbon Tetrachloride results in increased activity of GPT protein]; Telmisartan inhibits the reaction [Methotrexate results in increased expression of and results in increased secretion of GPT protein] |
CTD |
PMID:26929000 PMID:27269004 |
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Gsr |
glutathione reductase |
decreases activity multiple interactions |
ISO |
Telmisartan results in decreased activity of GSR protein Telmisartan inhibits the reaction [arsenite results in decreased activity of GSR protein] |
CTD |
PMID:34339004 |
|
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Hgf |
hepatocyte growth factor |
increases expression |
EXP |
telmisartan results in increased expression of HGF mRNA |
CTD |
PMID:21479465 |
|
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
|
|
G |
Hspa5 |
heat shock protein 5 |
decreases expression |
ISO |
telmisartan results in decreased expression of HSPA5 protein |
CTD |
PMID:19102871 |
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Ibsp |
integrin binding sialoprotein |
increases expression |
ISO |
telmisartan increases expression of mRNA in mandible of WKY rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr 5:104,447,153...104,459,338
Ensembl chr 5:104,447,037...104,459,335
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO EXP |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 protein] telmisartan inhibits the reaction [Streptozocin results in increased expression of ICAM1 mRNA] telmisartan inhibits the reaction [Daunorubicin results in increased expression of ICAM1 protein] |
CTD |
PMID:17724226 PMID:20888384 PMID:22124178 |
|
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Il10 |
interleukin 10 |
multiple interactions increases expression decreases expression |
ISO |
telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of IL10 protein] Telmisartan results in increased expression of IL10 protein telmisartan decreases expression of protein in mandible of WKY rats with periodontal disease |
CTD RGD |
PMID:24831514 PMID:29909460 PMID:33364953 |
RGD:329956421 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression |
ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] Telmisartan inhibits the reaction [AGT protein results in increased expression of IL1B protein]; Telmisartan inhibits the reaction [arsenite results in increased expression of IL1B protein] telmisartan decreases expression of protein in mandible of SHR rats with periodontal disease |
CTD RGD |
PMID:22124178 PMID:33872574 PMID:34339004 PMID:33364953 |
RGD:329956421 |
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il6 |
interleukin 6 |
multiple interactions decreases expression |
ISO EXP |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] telmisartan inhibits the reaction [AGT protein results in increased expression of IL6 protein]; telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 protein] 2-chloro-5-nitrobenzanilide inhibits the reaction [Telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; Telmisartan inhibits the reaction [AGT protein results in increased expression of IL6 protein]; Telmisartan inhibits the reaction [arsenite results in increased expression of IL6 protein]; Telmisartan inhibits the reaction [TNF protein promotes the reaction [CEBPB protein binds to IL6 promoter]]; Telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; Telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 protein] telmisartan results in decreased expression of IL6 mRNA Telmisartan results in decreased expression of IL6 protein |
CTD |
PMID:19289654 PMID:21479465 PMID:22124178 PMID:29909460 PMID:34339004 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Ins1 |
insulin I |
increases expression |
ISO |
Telmisartan results in increased expression of INS1 protein |
CTD |
PMID:19171132 |
|
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
|
|
G |
Ins2 |
insulin II |
decreases expression |
ISO |
telmisartan results in decreased expression of INS protein |
CTD |
PMID:15892894 |
|
NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
|
|
G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
multiple interactions |
ISO |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of IRAK1 mRNA |
CTD |
PMID:20524934 |
|
NCBI chr X:73,057,520...73,067,527
Ensembl chr X:73,057,520...73,067,524
|
|
G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
decreases expression |
ISO |
telmisartan decreases expression of KCNN4 mRNA and protein in CD4-positive alpha-beta T cell |
RGD |
PMID:26502942 |
RGD:329955577 |
NCBI chr 7:24,069,750...24,084,635
Ensembl chr 7:24,069,688...24,086,115
|
|
G |
Lepr |
leptin receptor |
multiple interactions |
EXP |
Telmisartan affects the reaction [LEPR protein affects the abundance of ALB protein]; Telmisartan affects the reaction [LEPR protein affects the expression of OCLN mRNA] |
CTD |
PMID:34464088 |
|
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
|
|
G |
Lipe |
lipase, hormone sensitive |
multiple interactions increases expression |
EXP |
PPARD promotes the reaction [telmisartan results in increased expression of LIPE protein] |
CTD |
PMID:20176998 |
|
NCBI chr 7:25,078,952...25,097,911
Ensembl chr 7:25,078,952...25,098,135
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein] Telmisartan inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:22124178 PMID:33872574 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
multiple interactions decreases phosphorylation |
ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK14 protein] telmisartan results in decreased phosphorylation of MAPK14 protein |
CTD |
PMID:19292980 PMID:22124178 |
|
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein] Telmisartan inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:22124178 PMID:33872574 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapkapk2 |
MAP kinase-activated protein kinase 2 |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Streptozocin results in increased expression of MAPKAPK2 protein modified form] |
CTD |
PMID:21381899 |
|
NCBI chr 1:130,981,437...131,025,580
Ensembl chr 1:130,981,437...131,025,563
|
|
G |
Mas1 |
MAS1 oncogene |
multiple interactions increases expression |
EXP ISO |
telmisartan inhibits the reaction [Streptozocin results in decreased expression of MAS1 protein] Telmisartan results in increased expression of MAS1 protein Telmisartan inhibits the reaction [Pregabalin results in decreased expression of MAS1 protein] |
CTD |
PMID:21381899 PMID:28656296 PMID:31629013 |
|
NCBI chr17:13,056,981...13,087,037
Ensembl chr17:13,059,966...13,087,030
|
|
G |
Mir146 |
microRNA 146 |
multiple interactions |
ISO |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of MIR146A telmisartan inhibits the reaction [ischemia-reperfusion injury increases expression of Mir146a miRNA in kidney] |
CTD RGD |
PMID:20524934 PMID:27760486 |
RGD:155882556 |
NCBI chr11:43,265,224...43,265,288
Ensembl chr11:43,265,224...43,265,288
|
|
G |
Mir146b |
microRNA 146b |
multiple interactions |
ISO |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of MIR146B |
CTD |
PMID:20524934 |
|
NCBI chr19:46,331,201...46,331,309
Ensembl chr19:46,331,201...46,331,309
|
|
G |
Mir320 |
microRNA 320 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [ischemia-reperfusion injury increases expression of Mir320a miRNA in kidney] |
RGD |
PMID:27760486 |
RGD:155882556 |
NCBI chr14:70,680,950...70,681,031
Ensembl chr14:70,680,950...70,681,031
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression decreases expression |
ISO |
telmisartan results in decreased expression of MMP2 protein telmisartan decreases expression of mRNA in mandible of WKY rats with periodontal disease |
CTD RGD |
PMID:21054405 PMID:33364953 |
RGD:329956421 |
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression |
ISO |
telmisartan decreases expression of mRNA in mandible of SHR rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP ISO |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [telmisartan inhibits the reaction [Streptozocin results in increased activity of MPO protein]]; telmisartan inhibits the reaction [Streptozocin results in increased activity of MPO protein] telmisartan inhibits the reaction [Carbon Tetrachloride results in increased activity of MPO protein]; telmisartan inhibits the reaction [sodium arsenite results in increased activity of MPO protein]; telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein] |
CTD |
PMID:23060470 PMID:24831514 PMID:26439596 PMID:26929000 |
|
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
|
|
G |
Mylk |
myosin, light polypeptide kinase |
multiple interactions |
ISO |
MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]]; Telmisartan inhibits the reaction [Glucose results in increased expression of MYLK mRNA]; Telmisartan inhibits the reaction [Glucose results in increased expression of MYLK protein] |
CTD |
PMID:34464088 |
|
NCBI chr16:34,565,569...34,822,806
Ensembl chr16:34,565,580...34,822,790
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions decreases expression |
EXP ISO |
telmisartan inhibits the reaction [Streptozocin results in increased expression of NCF1 protein] telmisartan results in decreased expression of NCF1 mRNA; telmisartan results in decreased expression of NCF1 protein telmisartan inhibits the reaction [Daunorubicin results in increased expression of NCF1 protein] |
CTD |
PMID:16141465 PMID:19171132 PMID:21054405 PMID:21381899 |
|
NCBI chr 5:134,248,907...134,258,479
Ensembl chr 5:134,248,907...134,258,479
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
multiple interactions decreases expression |
EXP ISO |
telmisartan inhibits the reaction [Streptozocin results in increased expression of NCF2 protein] telmisartan results in decreased expression of NCF2 mRNA; telmisartan results in decreased expression of NCF2 protein telmisartan inhibits the reaction [Daunorubicin results in increased expression of NCF2 protein] |
CTD |
PMID:16141465 PMID:21054405 PMID:21381899 |
|
NCBI chr 1:152,675,904...152,712,743
Ensembl chr 1:152,675,945...152,712,742
|
|
G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of NFKB1 protein] |
CTD |
PMID:21620867 |
|
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
|
|
G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
multiple interactions |
ISO |
PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA] |
CTD |
PMID:22124178 |
|
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions |
EXP ISO |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of NOS2 protein]; telmisartan inhibits the reaction [sodium arsenite results in increased expression of NOS2 protein] Telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of NOS2 protein]; Telmisartan inhibits the reaction [Carbon Tetrachloride results in increased expression of NOS2 protein]; Telmisartan inhibits the reaction [Methotrexate results in increased expression of NOS2 protein]; Telmisartan inhibits the reaction [sodium arsenite results in increased expression of NOS2]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of NOS2 mRNA] |
CTD |
PMID:21620867 PMID:21819444 PMID:22750630 PMID:24831514 PMID:26439596 PMID:26929000 PMID:27269004 More...
|
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
multiple interactions increases expression increases phosphorylation |
EXP |
2-chloro-5-nitrobenzanilide inhibits the reaction [Telmisartan results in increased expression of NOS3 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Telmisartan results in increased phosphorylation of NOS3 protein] telmisartan results in increased expression of NOS3 protein telmisartan results in increased phosphorylation of NOS3 protein |
CTD |
PMID:21156825 |
|
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Daunorubicin results in increased expression of NOX4 protein] |
CTD |
PMID:21054405 |
|
NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918
|
|
G |
Nppb |
natriuretic peptide type B |
affects expression decreases expression multiple interactions |
ISO |
telmisartan affects the expression of NPPB protein telmisartan results in decreased expression of NPPB protein Telmisartan inhibits the reaction [Pregabalin results in increased expression of NPPB protein] |
CTD |
PMID:16671338 PMID:18712048 PMID:31629013 |
|
NCBI chr 4:148,070,264...148,071,662
Ensembl chr 4:148,070,245...148,071,662
|
|
G |
Ocln |
occludin |
multiple interactions |
EXP ISO |
Telmisartan affects the reaction [LEPR protein affects the expression of OCLN mRNA] MYLK protein inhibits the reaction [Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]]; Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN mRNA]; Telmisartan inhibits the reaction [Glucose results in decreased expression of OCLN protein] |
CTD |
PMID:34464088 |
|
NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
|
|
G |
Olr1 |
oxidized low density lipoprotein (lectin-like) receptor 1 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of OLR1 mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of OLR1 protein] |
CTD |
PMID:22124178 |
|
NCBI chr 6:129,456,113...129,484,312
Ensembl chr 6:129,462,207...129,484,128
|
|
G |
Plau |
plasminogen activator, urokinase |
multiple interactions |
ISO |
telmisartan inhibits the reaction [AGT protein results in decreased expression of PLAU mRNA] |
CTD |
PMID:19706694 |
|
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
|
|
G |
Ppard |
peroxisome proliferator activator receptor delta |
multiple interactions increases expression |
EXP ISO |
PPARD promotes the reaction [Telmisartan results in increased expression of LIPE protein]; PPARD promotes the reaction [Telmisartan results in increased expression of UCP1 protein]; PPARD promotes the reaction [Telmisartan results in increased expression of UCP2 protein]; PPARD promotes the reaction [Telmisartan results in increased expression of UCP3 protein] telmisartan results in increased expression of PPARD protein |
CTD |
PMID:20176998 |
|
NCBI chr17:28,451,715...28,520,446
Ensembl chr17:28,451,674...28,520,448
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
multiple interactions increases activity increases expression |
ISO EXP |
PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]]; PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; PPARG mutant form inhibits the reaction [telmisartan results in increased expression of ABCG1 mRNA]; PPARG mutant form inhibits the reaction [telmisartan results in increased expression of CD36 mRNA]; PPARG protein promotes the reaction [telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein]] Telmisartan results in increased activity of PPARG protein telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] telmisartan results in increased expression of PPARG protein telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]; telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein] |
CTD |
PMID:18158351 PMID:20176998 PMID:20888384 PMID:21381899 PMID:22124178 PMID:24831514 PMID:28728110 More...
|
|
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
|
|
G |
Ppargc1a |
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
multiple interactions |
EXP |
telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARGC1A protein] |
CTD |
PMID:21381899 |
|
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
|
|
G |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [Dibutyl Phthalate results in increased expression of PRKAA2 protein] |
CTD |
PMID:37356649 |
|
NCBI chr 4:104,886,846...104,967,095
Ensembl chr 4:104,887,071...104,967,087
|
|
G |
Prkaca |
protein kinase, cAMP dependent, catalytic, alpha |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [Pregabalin results in decreased expression of PRKACA protein] |
CTD |
PMID:31629013 |
|
NCBI chr 8:84,699,607...84,723,073
Ensembl chr 8:84,699,622...84,723,072
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases activity |
ISO EXP |
telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] [Telmisartan co-treated with Aspirin] inhibits the reaction [Streptozocin results in increased expression of PTGS2 protein]; Telmisartan inhibits the reaction [arsenite results in increased activity of PTGS2 protein]; Telmisartan inhibits the reaction [Carbon Tetrachloride results in increased expression of PTGS2 protein]; Telmisartan inhibits the reaction [Daunorubicin results in increased expression of PTGS2 protein]; Telmisartan inhibits the reaction [Methotrexate results in increased expression of PTGS2 protein]; Telmisartan inhibits the reaction [sodium arsenite results in increased expression of PTGS2]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PTGS2 mRNA] telmisartan inhibits the reaction [sodium arsenite results in increased expression of PTGS2 protein] Telmisartan results in increased activity of PTGS2 protein |
CTD |
PMID:20223228 PMID:20888384 PMID:22124178 PMID:22750630 PMID:24831514 PMID:26439596 PMID:26929000 PMID:27269004 PMID:34339004 More...
|
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Pth1r |
parathyroid hormone 1 receptor |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of PTH1R protein] |
CTD |
PMID:23750309 |
|
NCBI chr 9:110,551,132...110,576,213
Ensembl chr 9:110,551,153...110,576,213
|
|
G |
Pthlh |
parathyroid hormone-like peptide |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of PTHLH protein] |
CTD |
PMID:23750309 |
|
NCBI chr 6:147,153,607...147,165,511
Ensembl chr 6:147,153,599...147,165,681
|
|
G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
multiple interactions |
ISO |
[telmisartan co-treated with Aspirin] inhibits the reaction [Streptozocin results in increased expression of RELA protein]; telmisartan inhibits the reaction [Carbon Tetrachloride results in increased expression of RELA protein]; telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RELA mRNA]; telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of RELA protein] telmisartan inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein] |
CTD |
PMID:20223228 PMID:22124178 PMID:24831514 PMID:26929000 |
|
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
|
|
G |
Ren1 |
renin 1 structural |
increases expression |
ISO |
telmisartan results in increased expression of REN mRNA; telmisartan results in increased expression of REN protein |
CTD |
PMID:9533614 |
|
NCBI chr 1:133,278,412...133,288,058
Ensembl chr 1:133,278,248...133,288,063
|
|
G |
Runx2 |
runt related transcription factor 2 |
increases expression |
ISO |
telmisartan increases expression of mRNA in mandible of rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr17:44,806,873...45,125,518
Ensembl chr17:44,806,874...45,125,684
|
|
G |
Scn5a |
sodium channel, voltage-gated, type V, alpha |
increases activity |
ISO |
telmisartan results in increased activity of SCN5A protein |
CTD |
PMID:29306026 |
|
NCBI chr 9:119,312,470...119,408,096
Ensembl chr 9:119,312,474...119,408,082
|
|
G |
Sema3b |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Calcitriol results in increased expression of SEMA3B protein]; telmisartan inhibits the reaction [Progesterone results in increased expression of SEMA3B protein] |
CTD |
PMID:21933904 |
|
NCBI chr 9:107,474,868...107,486,440
Ensembl chr 9:107,474,873...107,486,428
|
|
G |
Sema3f |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Calcitriol results in increased expression of SEMA3F protein]; telmisartan inhibits the reaction [Progesterone results in increased expression of SEMA3F protein] |
CTD |
PMID:21933904 |
|
NCBI chr 9:107,558,698...107,587,674
Ensembl chr 9:107,558,699...107,587,674
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
multiple interactions |
EXP ISO |
Telmisartan inhibits the reaction [[AGT protein modified form co-treated with AGTR1A co-treated with AGTR1B] results in increased expression of SERPINE1 mRNA]; Telmisartan inhibits the reaction [Hydrogen Peroxide results in increased expression of SERPINE1 mRNA] telmisartan inhibits the reaction [AGT protein results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:17620961 PMID:19706694 |
|
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
multiple interactions |
EXP |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC18A2 protein] |
CTD |
PMID:23747572 |
|
NCBI chr19:59,249,310...59,284,444
Ensembl chr19:59,249,328...59,284,444
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
|
|
G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
multiple interactions |
EXP |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC6A3 mRNA]; telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC6A3 protein] |
CTD |
PMID:23747572 |
|
NCBI chr13:73,684,270...73,726,791
Ensembl chr13:73,684,866...73,726,791
|
|
G |
Snca |
synuclein, alpha |
multiple interactions |
EXP |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SNCA mRNA]; telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of SNCA protein] |
CTD |
PMID:23747572 |
|
NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
|
|
G |
Sod1 |
superoxide dismutase 1, soluble |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [Methotrexate results in decreased expression of and results in decreased activity of SOD1 protein] |
CTD |
PMID:27269004 |
|
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
|
|
G |
Spmip11 |
sperm microtubule inner protein 11 |
multiple interactions |
ISO |
Telmisartan inhibits the reaction [Daunorubicin results in decreased expression of NPHS1 protein] |
CTD |
PMID:20888384 |
|
NCBI chr15:98,468,885...98,487,469
Ensembl chr15:98,468,885...98,487,461
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
increases expression |
ISO |
telmisartan increases expression of mRNA in mandible of WKY rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
|
|
G |
Syp |
synaptophysin |
multiple interactions |
EXP ISO |
telmisartan inhibits the reaction [Streptozocin results in decreased expression of SYP protein] telmisartan inhibits the reaction [AGT protein results in decreased expression of SYP protein]; telmisartan inhibits the reaction [AGT protein results in increased ubiquitination of SYP protein] |
CTD |
PMID:18487452 |
|
NCBI chr X:7,504,819...7,519,495
Ensembl chr X:7,504,710...7,519,495
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions decreases expression |
EXP ISO |
telmisartan inhibits the reaction [Streptozocin results in increased expression of TGFB1 protein] telmisartan inhibits the reaction [AGT protein results in increased expression of TGFB1 mRNA]; telmisartan inhibits the reaction [AGT protein results in increased expression of TGFB1 protein]; telmisartan inhibits the reaction [Daunorubicin results in increased expression of TGFB1 protein] telmisartan results in decreased expression of TGFB1 mRNA |
CTD |
PMID:19171132 PMID:19706694 PMID:20888384 PMID:21381899 |
|
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
EXP |
telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH mRNA]; telmisartan inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH protein] |
CTD |
PMID:23747572 |
|
NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions affects localization decreases expression |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan affects the localization of TJP1 protein]; 2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan results in decreased expression of TJP1 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan results in decreased expression of TJP1 protein]; wortmannin inhibits the reaction [telmisartan affects the localization of TJP1 protein]; wortmannin inhibits the reaction [telmisartan results in decreased expression of TJP1 mRNA]; wortmannin inhibits the reaction [telmisartan results in decreased expression of TJP1 protein] telmisartan results in decreased expression of TJP1 mRNA; telmisartan results in decreased expression of TJP1 protein |
CTD |
PMID:19252288 |
|
NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of TLR4 mRNA; [Atorvastatin co-treated with Telmisartan] results in decreased expression of TLR4 protein |
CTD |
PMID:20524934 |
|
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression decreases expression |
ISO EXP |
PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; T 0070907 inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; T 0070907 inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; telmisartan inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] 2-chloro-5-nitrobenzanilide inhibits the reaction [Telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]]; [Telmisartan co-treated with Aspirin] inhibits the reaction [Streptozocin results in increased expression of TNF protein]; Telmisartan inhibits the reaction [arsenite results in increased expression of TNF protein]; Telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of TNF]; Telmisartan inhibits the reaction [Carbon Tetrachloride results in increased expression of TNF protein]; Telmisartan inhibits the reaction [sodium arsenite results in increased expression of TNF]; Telmisartan inhibits the reaction [TNF protein promotes the reaction [CEBPB protein binds to IL6 promoter]]; Telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; Telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 protein]; Telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TNF protein] telmisartan inhibits the reaction [Cadmium Chloride results in increased expression of TNF protein]; telmisartan inhibits the reaction [sodium arsenite results in increased expression of TNF protein]; telmisartan inhibits the reaction [TNF protein results in increased expression of IL6 protein] Telmisartan results in decreased expression of TNF protein telmisartan decreases expression of protein in mandible of SHR rats with periodontal disease |
CTD RGD |
PMID:19289654 PMID:20223228 PMID:21620867 PMID:21819444 PMID:22124178 PMID:22750630 PMID:24831514 PMID:26439596 PMID:26929000 PMID:29909460 PMID:34339004 PMID:33364953 More...
|
RGD:329956421 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
increases expression |
ISO |
telmisartan increases expression of mRNA in mandible of WKY rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr15:54,114,014...54,141,700
Ensembl chr15:54,114,015...54,141,880
|
|
G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
decreases expression |
ISO |
telmisartan decreases expression of mRNA in mandible of SHR rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr14:78,514,886...78,545,483
Ensembl chr14:78,514,885...78,545,483
|
|
G |
Traf6 |
TNF receptor-associated factor 6 |
multiple interactions |
ISO |
[Atorvastatin co-treated with Telmisartan] results in decreased expression of TRAF6 mRNA |
CTD |
PMID:20524934 |
|
NCBI chr 2:101,508,765...101,532,013
Ensembl chr 2:101,508,774...101,532,014
|
|
G |
Ucp1 |
uncoupling protein 1 (mitochondrial, proton carrier) |
multiple interactions increases expression |
EXP |
PPARD promotes the reaction [telmisartan results in increased expression of UCP1 protein] |
CTD |
PMID:20176998 |
|
NCBI chr 8:84,016,977...84,025,085
Ensembl chr 8:84,016,981...84,025,081
|
|
G |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
multiple interactions increases expression |
EXP |
PPARD promotes the reaction [telmisartan results in increased expression of UCP2 protein] |
CTD |
PMID:20176998 |
|
NCBI chr 7:100,142,565...100,148,832
Ensembl chr 7:100,142,544...100,151,227
|
|
G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
multiple interactions increases expression |
EXP |
PPARD promotes the reaction [telmisartan results in increased expression of UCP3 protein] |
CTD |
PMID:20176998 |
|
NCBI chr 7:100,122,198...100,135,639
Ensembl chr 7:100,122,197...100,135,639
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
multiple interactions |
ISO |
telmisartan inhibits the reaction [Daunorubicin results in increased expression of VCAM1 protein] |
CTD |
PMID:20888384 |
|
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions decreases expression |
EXP ISO |
telmisartan inhibits the reaction [Streptozocin results in increased expression of VEGFA mRNA] telmisartan results in decreased expression of VEGFA mRNA telmisartan inhibits the reaction [sodium arsenite results in increased expression of VEGFA] |
CTD |
PMID:17724226 PMID:19171132 PMID:26439596 |
|
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
|
|
G |
Vtn |
vitronectin |
decreases expression |
ISO |
telmisartan decreases expression of mRNA in mandible of SHR rats with periodontal disease |
RGD |
PMID:33364953 |
RGD:329956421 |
NCBI chr11:78,389,946...78,393,151
Ensembl chr11:78,389,917...78,393,150
|
|